Independent fund research. Built on SEC filings.

How we research funds

Guggenheim · Technology Sector

Biotechnology Fund: share classes compared

Biotechnology Fund has 4 share classes. They hold the same portfolio — $137 million in total — but charge different fees and loads. The cheapest is RYOIX (Investor Class) at 1.38%.

TickerShare classTypeExpense ratioFront load12b-11-yr5-yr10-yr
RYOIXInvestor ClassMutual fund 1.38%—0% +30.7%+4.0%+5.9%
RYBOXClass AMutual fund 1.63%4.75%0.25% +24.2%+2.8%+5.1%
RYOAXClass HMutual fund 1.63%—0.25% +30.4%+3.8%+5.6%
RYCFXClass CMutual fund 2.38%0%1% +28.4%+3.0%+4.8%

Source: Fund prospectus, filed Jul 29, 2026

Objective

The Biotechnology Fund (the Fund) seeks to provide capital appreciation by investing in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products or services (Biotechnology Companies).

Top holdings

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%